Angelman syndrome: A review highlighting musculoskeletal and anatomical aberrations

Clinical Anatomy

Volumn 29, Issue 5, 2016, Pages 561-567

  Sachdeva, Rohit ^a   Donkers, Sarah J ^a   Kim, Soo Y ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

chromosomal disease; craniofacial; Happy Puppet syndrome; neurodevelopmental disorder

Indexed keywords

BRACHYCEPHALY; CLINICAL FEATURE; CRANIOFACIAL MALFORMATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HAPPY PUPPET SYNDROME; HUMAN; JOINT CONTRACTURE; MICROCEPHALY; MUSCULOSKELETAL DISEASE; NONHUMAN; PATHOGENESIS; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNATHIA; PROGNOSIS; QUALITY OF LIFE; REVIEW; SCOLIOSIS; TREATMENT PLANNING;

EID: 84990224013     PISSN: 08973806     EISSN: 10982353     Source Type: Journal    
DOI: 10.1002/ca.22659     Document Type: Review

References (60)

1. Allen KD, Kuhn BR, DeHaai KA, Wallace DP. 2013. Evaluation of a behavioral treatment package to reduce sleep problems in children with Angelman syndrome. Res Dev Disabil 34:676–686.
2. Angelman H. 1965. ‘Puppet’children a report on three cases. Dev Med Child Neurol 7:681–688.
3. Bird LM. 2014. Angelman syndrome: Review of clinical and molecular aspects. Appl Clin Genet 7:93–104.
4. Bird LM, Tan W, Bacino CA, Peters SU, Skinner SA, Anselm I, Barbieri-Welge R, Bauer-Carlin A, Gentile JK, Glaze DG. 2011. A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome. Am J Med Genet a 155:2956–2963.
5. Berg JM, Pakula Z. 1972. Angelman's (Happy Puppet) Syndrome. Am J Dis Child 123:72–74.
6. Bower BD, Jeavons PM. 1967. The “Happy Puppet” syndrome. Arch Dis Child 42:298–302.
7. Boyd S, Harden A, Patton M. 1988. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr 147:508–513.
8. Buckley RH, Dinno N, Weber P. 1998. Angelman syndrome: Are the estimates too low? Am J Med Genet 80:385–390.
9. Budisteanu M, Papuc SM, Tutulan-Cunita A, Craiu D, Barca D, Iliescu C, Arghir A. 2013. Angelman syndrome patient management: 5 Years of clinical experience. Int J Disabil Hum Develop 12:379–384.
10. Buerger J, Kunze J, Sperling K, Reis A. 1996. Phenotypic differences in Angelman syndrome patients: Imprinting mutations show less frequently microcephaly and hypopigmentation than deletions. Am J Med Genet 66:221–226.
11. Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S, Nicholls RD, Horsthemke B. 1995. Inherited microdeletions in the Angelman and Prader–Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet 9:395–400.
12. Buntinx IM, Hennekam R, Brouwer OF, Stroink H, Beuten J, Mangelschots K, Fryns J. 1995. Clinical profile of Angelman syndrome at different ages. Am J Med Genet 56:176–183.
13. Cassidy SB, Allanson JE. 2005. Management of Genetic Syndromes. 2nd Ed. New Jersey: Wiley. p 53–62.
14. Cassidy SB, Schwartz S. 1998. Prader-Willi and Angelman syndromes: Disorders of genomic imprinting. Medicine 77:140–151.
15. Clayton-Smith J. 1993. Clinical research on Angelman syndrome in the United Kingdom: Observations on 82 affected individuals. Am J Med Genet 46:12–15.
16. Clayton-Smith J. 2001. Angelman syndrome: evolution of the phenotype in adolescents and adults. Dev Med Child Neurol 43:476–480.
17. Clayton-Smith J, Laan L. 2003. Angelman syndrome: A review of the clinical and genetic aspects. J Med Genet 40:87–95.
18. Clayton-Smith J, Pembrey ME. 1992. Angelman syndrome. J Med Genet 29:412–415.
19. de Queiroz AM, de Siqueira Melara T, Fernandes Ferreira PD, Lucisano MP, De Rossi A, Nelson-Filho P Bezerra Silva RA. 2013. Dental findings and special care in patients with Angelman syndrome: A report of three cases. Spec Care Dentist 33:40–45.
20. Dörries A, Spohr H, Kunze J. 1988. Angelman (“happy puppet”) syndrome—Seven new cases documented by cerebral computed tomography: review of the literature. Eur J Pediatr 148:270–273.
21. Elian M. 1975. Fourteen happy puppets. Clin Pediatr (Phila) 14:902–908.
22. Fisher JA, Burn J, Alexander FW, Gardner-Medwin D. 1987. Angelman (happy puppet) syndrome in a girl and her brother. J Med Genet 24:294–298.
23. Gilfillan GD, Selmer KK, Roxrud I, Smith R, Kyllerman M, Eiklid K, Kroken M, Mattingsdal M, Egeland T, Stenmark H. 2008. SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Am J Hum Genet 82:1003–1010.
24. Guerrini R, Carrozzo R, Rinaldi R, Bonanni P. 2003. Angelman syndrome. Pediatric Drugs 5:647–661.
25. Huang H, Allen JA, Mabb AM, King IF, Miriyala J, Taylor-Blake B, Sciaky N, Dutton JW, Lee H, Chen X. 2012. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481:185–189.
26. Jiang Y, Lev-Lehman E, Bressler J, Tsai T, Beaudet AL. 1999. Genetics of Angelman syndrome. Am J Hum Genet 65:1–6.
27. Kara OK, Mutlu A, Gunel MK, Haliloglu G. 2010. Do the physiotherapy results make us happy in a case with 'happy puppet' (Angelman) syndrome? BMJ Case Rep 2010:10–1136. /bcr.06.2010.3081.
28. Kuroki Y, Matsui I, Yamamoto Y, Ieshima A. 1980. The “happy puppet” syndrome in two siblings. Hum Genet 56:227–229.
29. Kyllerman M. 1995. On the prevalence of Angelman syndrome. Am J Med Genet 59:405–405.
30. Laan LA, v Haeringen A, Brouwer OF. 1999. Angelman syndrome: A review of clinical and genetic aspects. Clin Neurol Neurosurg 101:161–170.
31. Lee S, Nicholls RD, Bundey S, Laxova R, Musarella M, Spritz RA. 1994. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med 330:529–534.
32. Lossie AC, Whitney MM, Amidon D, Dong HJ, Chen P, Theriaque D, Hutson A, Nicholls RD, Zori RT, Williams CA, Driscoll DJ. 2001. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38:834–845.
33. Malzac P, Webber H, Moncla A, Graham JM, Kukolich M, Williams C, Pagon RA, Ramsdell LA, Kishino T, Wagstaff J. 1998. Mutation analysis of UBE3A in Angelman syndrome patients. Am J Hum Genet 62:1353–1360.
34. Margolis SS, Sell GL, Zbinden MA, Bird LM. 2015. Angelman syndrome. Neurotherapeutics 12:641–650.
35. Mayo O, Nelson MM, Townsend H. 1973. Three more ‘happy puppets’. Dev Med Child Neurol 15:63–69.
36. Meng L, Ward AJ, Chun S, Bennett CF, Beaudet AL, Rigo F. 2014. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature 19:409–412.
37. Moncla A, Malzac P, Livet MO, Voelckel MA, Mancini J, Delaroziere JC, Philip N, Mattei JF. 1999. Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: Clinical manifestations and genetic counselling. J Med Genet 36:554–560.
38. Moore JR, Jeavons PM. 1973. The “happy puppet” syndrome: two new cases and a review of five previous cases. Neuropadiatrie 4:172–179.
39. Õiglane-Shlik E, Talvik T, Žordania R, Poder H, Kahre T, Raukas E, Ilus T, Tasa G, Bartsch O Väisänen M. 2006. Prevalence of Angelman syndrome and Prader–Willi syndrome in Estonian children: Sister syndromes not equally represented. Am J Med Genet A 140:1936–1943.
40. Peters SU, Bird LM, Kimonis V, Glaze DG, Shinawi LM, Bichell TJ, Barbieri-Welge R, Nespeca M, Anselm I, Waisbren S. 2010. Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid. Am J Med Genet A 152:1994–2001.
41. Petersen MB, Brøndum-Nielsen K, Hansen LK, Wulff K. 1995. Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county. Am J Med Genet 60:261–262.
42. Powell WT, Coulson RL, Gonzales ML, Crary FK, Wong SS, Adams S, Ach RA, Tsang P, Yamada NA, Yasui DH, Chedin F, LaSalle JM. 2013. R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc Natl Acad Sci U S A 110:13938–13943.
43. Robb SA, Pohl KR, Baraitser M, Wilson J, Brett EM. 1989. The 'happy puppet' syndrome of Angelman: Review of the clinical features. Arch Dis Child 64:83–86.
44. Saitoh S, Harada N, Jinno Y, Hashimoto K, Imaizumi K, Kuroki Y, Fukushima Y, Sugimoto T, Renedo M, Wagstaff J. 1994. Molecular and clinical study of 61 Angelman syndrome patients. Am J Med Genet 52:158–163.
45. Scheffer I, Brett EM, Wilson J, Baraitser M. 1990. Angelman's syndrome. J Med Genet 27:275–277.
46. Smith A, Wiles C, Haan E, McGill J, Wallace G, Dixon J, Selby R, Colley A, Marks R, Trent RJ. 1996. Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion. J Med Genet 33:107–112.
47. Tan W, Bacino CA, Skinner SA, Anselm I, Barbieri-Welge R, Bauer-Carlin A, Beaudet AL, Bichell TJ, Gentile JK, Glaze DG. 2011. Angelman syndrome: Mutations influence features in early childhood. Am J Med Genet a 155:81–90.
48. Thibert RL, Conant KD, Braun EK, Bruno P, Said RR, Nespeca MP, Thiele EA. 2009. Epilepsy in Angelman syndrome: A questionnaire-based assessment of the natural history and current treatment options. Epilepsia 50:2369–2376.
49. Thibert RL, Larson AM, Hsieh DT, Raby AR, Thiele EA. 2013. Neurologic manifestations of Angelman syndrome. Pediatr Neurol 48:271–279.
50. Thomson A, Glasson E, Bittles A. 2006. A long-term population-based clinical and morbidity profile of Angelman syndrome in Western Australia: 1953–2003. Disabil Rehabil 28:299–305.
51. Valente KD, Koiffmann CP, Fridman C, Varella M, Kok F, Andrade JQ, Grossmann RM, Marques-Dias MJ. 2006. Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13. Arch Neurol 63:122–128.
52. Weeber E. 2012. Minocycline in the Angelman Syndrome. URL: https://clinicaltrials.gov/ct2/show/NCT01531582 [accessed August 2015]
53. Tan W. 2011. A trial of levodopa in Angelman Syndrome. URL: https://clinicaltrials.gov/ct2/show/NCT01281475 [accessed August 2015]
54. Wilkie AO, Zeitlin HC, Lindenbaum RH, Buckle VJ, Fischel-Ghodsian N, Chui DH, Gardner-Medwin D, MacGillivray MH, Weatherall DJ, Higgs DR. 1990. Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet 46:1127–1140.
55. Williams CA. 1995. Angelman syndrome: Consensus for diagnostic criteria. Am J Med Genet 56:237–238.
56. Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A, Schinzel AA, Summers JA. 2006. Angelman syndrome 2005: Updated consensus for diagnostic criteria. Am J Med Genet a 140:413–418.
57. Williams CA, Lossie A, Driscoll D. 2001. Angelman syndrome: Mimicking conditions and phenotypes. Am J Med Genet 101:59–64.
58. Yamada KA, Volpe JJ. 1990. Angelman's syndrome in infancy. Dev Med Child Neurol 32:1005–1011.
59. Yiş U, Giray Ö, Kurul SH, Bora E, Ulgenalp A, Erçal D, Dirik E. 2008. Long-standing fever and Angelman syndrome: Report of two cases. J Paediatr Child Health 44:308–310.
60. Zori RT, Hendrickson J, Woolven S, Whidden EM, Gray B, Williams CA. 1992. Angelman syndrome: Clinical profile. J Child Neurol 7:270–280.